- Home
- CNVS vs ALGS Comparison
CNVS vs ALGS Comparison
Compare CNVS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNVS | ALGS |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.1M | 49.7M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CNVS | ALGS |
|---|---|---|
| Price | $3.10 | $7.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 434.7K | 41.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $78,181,000.00 | $3,611,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.92 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 59.13 | N/A |
| 52 Week Low | $1.77 | $3.76 |
| 52 Week High | $7.39 | $17.39 |
Technical Indicators
Market Signals| Indicator | CNVS | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 70.72 | 47.07 |
| Support Level | $2.47 | $6.92 |
| Resistance Level | $3.49 | $8.84 |
| Average True Range (ATR) | 0.29 | 0.56 |
| MACD | 0.09 | 0.09 |
| Stochastic Oscillator | 79.65 | 69.28 |
Price Performance
Historical ComparisonAbout CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.